belagavi news

lcds-Belagavi-news

Zydus Cadila’s ZyCoV-D clinical trials commenced in Belagavi

Photo of author

 

Bharat Biotech announced the initiation of Covaxin’s phase-1 clinical trials has commenced at Jeevan Rekha Hospital Belagavi.

Now the clinical trial of another vaccine made by Zydus Cadila named ZyCoV-D has also commenced the phase II clinical trial of its Covid-19 vaccine candidate at Jeevan Rekha Hospital Belagavi.

ZyCoV-D was found to be safe and well-tolerated in phase I clinical trial. The company will now commence phase II clinical trials from the 6th of August, 2020.

zydus-covd


Earlier this month, Zydus had received approval from domestic authorities to start human trials for its COVID-19 vaccine contender – the second Indian pharmaceutical firm to get such nod amid a surge in novel coronavirus infections worldwide.

In phase II clinical trials, they look forward to evaluating the safety and immunogenicity of the vaccine in a larger population.

1 thought on “Zydus Cadila’s ZyCoV-D clinical trials commenced in Belagavi”

Leave a Comment